Comparison of anti-diabetic drug prescribing in children and adolescents in seven European countries

British Journal of Clinical Pharmacology

Volumn 72, Issue 6, 2011, Pages 969-977

  Neubert, Antje ^a,b   Hsia, Yingfen ^a   de Jong van den Berg, Lolkje T W ^c   Janhsen, Katrin ^d,e   Glaeske, Gerd ^d   Furu, Kari ^f   Kieler, Helle ^g   Nørgaard, Mette ^h   Clavenna, Antonio ⁱ   Wong, Ian C K ^a,j  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY OF BREMEN   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^g KAROLINSKA INSTITUTE   (Sweden)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

ⁱ MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^j UNIVERSITY OF HONG KONG   (Hong Kong)

more..

Author keywords

Adolescents; Children; Insulin; Oral anti diabetics; Type 1 diabetes; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE; BOVINE INSULIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; METFORMIN; ORAL ANTIDIABETIC AGENT; PIG INSULIN; SULFONAMIDE; UREA DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; EUROPE; FEMALE; FINLAND; GERMANY; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; ITALY; MAJOR CLINICAL STUDY; MALE; MONITORING; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; PRESCHOOL CHILD; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SWEDEN; UNITED KINGDOM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EUROPE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INSULIN; MALE; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE;

EID: 80855138615     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2011.04045.x     Document Type: Article

References (26)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31.
3. Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002; 51: 3353-61.
4. Haines L, Wan KC, Lynn R, Barrett TG, Shield JP. Rising incidence of type 2 diabetes in children in the U.K. Diabetes Care 2007; 30: 1097-101.
5. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009; 373: 2027-33.
6. Neubert A, Sturkenboom MC, Murray ML, Verhamme KM, Nicolosi A, Giaquinto C, Ceci A, Wong IC. Databases for pediatric medicine research in Europe - assessment and critical appraisal. Pharmacoepidemiol Drug Saf 2008; 17: 1155-67.
7. Hsia Y, Neubert AC, Rani F, Viner RM, Hindmarsh PC, Wong IC. An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database. Br J Clin Pharmacol 2009; 67: 242-9.
8. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. Norwegian Institute of Public Health. Internet. Oslo, Norway: Norwegian Institute of Public Health, 2009.
9. Sturkenboom MC, Verhamme KM, Nicolosi A, Murray ML, Neubert A, Caudri D, Picelli G, Sen EF, Giaquinto C, Cantarutti L, Baiardi P, Felisi MG, Ceci A, Wong IC. Drug use in children: cohort study in three European countries. BMJ 2008; 337: a2245.
10. Wong IC, Murray ML. The potential of UK clinical databases in enhancing paediatric medication research. Br J Clin Pharmacol 2005; 59: 750-5.
11. Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT. Pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Saf 2002; 11: 379-84.
12. Schirm E, Monster TB, de Vries R, van den Berg PB, de Jong-van den Berg LT, Tobi H. How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information. Pharmacoepidemiol Drug Saf 2004; 13: 173-9.
13. Fegert JM, Kolch M, Zito JM, Glaeske G, Janhsen K. Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol 2006; 16: 197-206.
14. Janhsen K. [Public health research with statutory health insurance drug data]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2004; 47: 521-5.
15. Wettermark B, Hammar N, Fored CM, Leimanis A, Olausson P, Bergman U, Persson I, Sundstrom A, Westerholm B, Rosen M. The new Swedish Prescribed Drug Register - opportunities for pharmacoepidemiological research and experience from the first six months 4. Pharmacoepidemiol Drug Saf 2007; 16: 726-35.
16. Furu K. Establishment of the nationwide Norwegian Prescription Database (NorPD) - New opportunities for research in pharmacoepidemiology in Norway. Norsk Epidemiol 2008; 18: 129-36.
17. Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sorensen HT. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 2010; 106: 86-94.
18. Clavenna A, Sequi M, Bortolotti A, Merlino L, Fortino I, Bonati M. Determinants of the drug utilization profile in the paediatric population in Italy's Lombardy Region. Br J Clin Pharmacol 2009; 67: 565-71.
19. Clavenna A, Sequi M, Bonati M. Drug prescribing by Italian family paediatricians: an exception? Acta Paediatr 2010; 99: 754-7.
20. Clavenna A, Sequi M, Bonati M. Differences in the drug prescriptions to children by Italian paediatricians and general practitioners. Eur J Clin Pharmacol 2010; 66: 519-24.
21. Ehehalt S, Popovic P, Muntoni S, Willasch A, Hub R, Ranke MB, Neu A; DIARY Group Baden Wuerttemberg. Incidence of diabetes mellitus among children of Italian migrants substantiates the role of genetic factors in the pathogenesis of type 1 diabetes. Eur J Pediatr 2009; 168: 613-7.
22. Muntoni S, Muntoni S. New Insights into the Epidemiology of Type 1 Diabetes in Mediterranean Countries. Diabtes Metab Res Rev 1999; 15: 133-40.
23. Green A, Gale EA, Patterson CC. Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study. Lancet 1992; 339: 905-9.
24. Owens DR, Zinman B, Bolli GB. Insulins today and beyond. Lancet 2001; 358: 739-46.
25. Mastorakos G, Lambrinoudaki I, Creatsas G. Polycystic ovary syndrome in adolescents: current and future treatment options. Paediatr Drugs 2006; 8: 311-8.
26. Park MH, Kinra S, Ward KJ, White B, Viner RM. Metformin for obesity in children and adolescents: a systematic review. Diabetes Care 2009; 32: 1743-5.